Navigation Links
Stomach receptor for H. pylori discovered

Scientists have determined that decay-accelerating factor (DAF), a protein found in epithelial cells in the stomach, acts as a receptor for the bacteria Helicobacter pylori. Blocking this interaction could lead to new drugs that reduce the risk of peptic ulcer disease or gastric cancer. The research appears as the "Paper of the Week" in the May 12 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molecular Biology journal.

Helicobacter pylori are spiral shaped bacteria that live in the thick layer of mucus that covers the stomach lining. The bacteria are found everywhere in the world, but are especially prevalent in developing countries, where up to 80% of children and 90% of adults can have laboratory evidence of an H. pylori infection--usually without having any symptoms.

The vast majority of H. pylori in colonized hosts are free-living, but approximately 20% bind to gastric epithelial cells. This binding induces an immune response and alters the morphology and behavior of the epithelial cells due to injection of bacterial proteins into the cells. This interaction can lead to peptic ulcer disease, gastric adenocarcinoma, and non-Hodgkins lymphoma of the stomach.

"Ulcers are a breach in the gastric or duodenal mucosa and gastric adenocarcinoma is one type of cancer of the stomach," explains senior author Dr. Richard M. Peek, Jr. of the Vanderbilt University School of Medicine. "H. pylori alters acid production and can lead to increased acid outputs which causes peptic ulcer disease. The means through which H. pylori causes gastric cancer are more complex but likely involve alterations in gastric epithelial cell responses that are perturbed within the context of a chronic gastric inflammatory infiltrate, which can persist for decades."

A membrane-imbedded protein found in the stomach called decay-accelerating factor (DAF) has been shown to function as a receptor for several microbial pathogens. Peek and his colleagues were curious as to whether DAF was also involved in H. pylori adherence. To do this, the researchers measured the number of H. pylori that bound to cells that either expressed or did not express DAF. They found that the bacteria do indeed adhere to cells with DAF. They also discovered that H. pylori induce DAF expression in cultured gastric epithelial cells and that mice lacking DAF develop attenuated stomach inflammation.

"Our results indicate that H. pylori can co-opt a host protein as a receptor and that it can increase expression of this receptor in gastric epithelial cells," says Peek. "Further, absence of this receptor abolishes the inflammatory response that H. pylori induces in infected mice, suggesting that this receptor mediates H. pylori-induced injury in the stomach."

These findings suggest that drugs that interfere with DAF binding could be used to prevent or treat peptic ulcer disease or distal gastric adenocarcinoma. These new drugs will be a welcome alternative to the current treatment for H. pylori infections which typically involves taking 3 to 4 medications over a 10 to 14 day period.


'"/>

Source:American Society for Biochemistry and Molecular Biology


Related biology news :

1. Activation of thermoreceptors mediates raw garlics burning pungency
2. Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage
3. Small worm yields big clue on muscle receptor action
4. Evolution of taste receptor may have shaped human sensitivity to toxic compounds
5. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
6. Bats use touch receptors on wings to fly, catch prey, study finds
7. HIV accessory protein disables host immunity via receptor-protein intermediary
8. Manipulating single cell receptor alters animal behavior
9. Nano-keys bind cell receptors and trigger allergic reactions
10. Variation in bitter-taste receptor gene increases risk for alcoholism
11. Protein receptor cools passion of kiss and run nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... 20, 2018 , ... We are excited to announce the ... the recently launched NovoCyte QuanteonTM flow cytometers and NovoSampler® Q ... , In addition to the functionalities supporting the expanded flow cytometer ...
(Date:9/15/2018)... , ... September 14, 2018 , ... The first ever ... of clearance of green, blue, and purple tattoo inks - often the colors most ... Medicine (LSM), the official journal of the American Society for Laser Medicine and Surgery, ...
(Date:9/12/2018)... Mass. (PRWEB) , ... September 12, 2018 , ... ... for scientific research and education, is pleased to support the professional development of ... in Charleston, South Carolina. , The entrants were asked to submit successful strategies ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... Calif. (PRWEB) , ... August 28, 2018 , ... ... will be presenting the results of a safety study performed on an allogeneic ... North American Veterinary Regenerative Medicine Association (NAVRMA) conference in September. He is ...
(Date:8/26/2018)... YORBA LINDA, Calif. (PRWEB) , ... August 23, ... ... interactive virtual events for tech innovators, engineers, and scientists from around the world, ... and Immunology 2018 will cover an array of industries and disciplines, encompassing various ...
(Date:8/23/2018)... N.J. (PRWEB) , ... August 23, 2018 , ... ... by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers Technology ... later. , Visikol’s path from an idea to a successful biotech company has ...
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the new ... Chemko Technical Services in 2016. Chemko had a well established local presence, servicing the ... KSC on projects such as the ongoing work at the Mobile Launch Platform (MLP) ...
Breaking Biology Technology: